BioSpace News Archive

Easton Pharma / Alliance Group Awaits Equipment Delivery, Days Away From Commencing Operations on its Aggregate Contract After Closing $1.3M JV Agreement for 50% Property Ownership Interest and Various Business

Once delivered, operations will commence which should then allow for additional contracts currently under negotiations to close.

November 28, 2017
·
5 min read
Business

ImmunoMet Appoints Briggs W. Morrison, M.D., and Paul Lammers, M.D., M.Sc., to Board of Directors

Dr. Morrison currently serves as the CEO and is a member of the board of directors of Syndax.

November 28, 2017
·
4 min read
Biotech Beach

OncoSec Expands Intellectual Property Estate, Announces Issuance of Patents for ImmunoPulse Platform

OncoSec Medical today announced that it has added two patents to its broad patent portfolio.

November 28, 2017
·
5 min read
Deals

WIRB-Copernicus Group Acquires Vigilare International

Financial details about the transaction were not disclosed.

November 28, 2017
·
2 min read
Business

Genomic Health and Cleveland Diagnostics Announce Strategic Collaboration to Develop and Commercialize New Prostate Cancer Tests

Initial efforts under this agreement will focus on Genomic Health’s development of a high-PSA reflex test to accurately predict the presence of high-grade cancer prior to prostate biopsy.

November 28, 2017
·
9 min read
Aytu BioScience Provides Update on the Continued Growth of Natesto in the U.S.

Significant Natesto prescription growth continued through October 2017, with prescriptions increasing 17% from the previous month, reaching their highest levels to date.

November 28, 2017
·
5 min read
Business

Varian Partners With Penn Medicine for Proton Therapy Training and Education Program

The program will cover all aspects of proton therapy, from patient selection and planning through treatment and follow-up.

November 28, 2017
·
1 min read
Business

X-Chem and Gilead Announce Drug Discovery Collaboration

Agreement leverages X-Chem’s DEX DNA-Encoded Libraries and Gilead’s proprietary know-how to enable the discovery of new chemical entities.

November 28, 2017
·
3 min read
Drug Development

Enrollment Completed in Flex Pharma’s Phase II Exploratory Spasticity Study in MS

The randomized, placebo-controlled, blinded, cross-over study is designed to evaluate the safety and efficacy of FLX-787.

November 28, 2017
·
5 min read
Bio NC

IQVIA Announces Pricing of Secondary Public Offering

The Repurchase will be completed outside IQVIA’s existing share repurchase program, under which IQVIA has approximately $195 million of remaining availability.

November 28, 2017
·
3 min read